Hypera Pharma
Manufacturing · Brazil · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Edifficio Continental Tower 22 Av. Magal...Website
www.hyperapharma.com.brRevenue
$1 BillionStock Symbol
HYPE3Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Hypera Pharma
Founded in 2001, Hyper Pharma is a full service pharmaceutical company. Hyper Pharma is divided into three business segements, prescription products, consumer health, and generic and similar brand prescriptions. Hyper Pharma is headquartered out of Sao Paulo, Brazil.Explore more
Hypera Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hypera Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Hypera Pharma has new funding data
Hypera Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Hypera Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Hypera Pharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Hypera Pharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Hypera Pharma had a recent Job posting/layoffs
Product Launch: Get notified when Hypera Pharma launches new products
Check out if Hypera Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Hypera Pharma
Find 2 more new buyers
Company Profile Activity
Activity Insights
Hypera Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hypera Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hypera Pharma.
Hypera Pharma Tech Stack
A closer look at the technologies used by Hypera Pharma
See more technologies
Most Recent Scoops
Left Company
Executive Move
Carlos Filho, Treasury Coordinator, has left the organization and now serves as the Chief of Staff at SmartMEI.
Left Company
Fabricio Diel, director, operations, has left the organization.
Promotion
Mergers & Acquisitions (M&A)
Product Management
Mergers & Acquisitions (M&A)
Hypera Pharma News & Media
Takeda conclude la vendita a Hypera Pharma di una selezione di prodotti non strategici e da banco
OSAKA, Giappone--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") oggi ha annunciato la conclusione della preannunciata vendita a Hypera S.A. ("Hypera Pharma") di un portafoglio di prodotti scelti, commercializzati in America Latina, di valore complessivo pari a 825 milioni di dollari. L'accordo per la dismissione era stato annunciato a marzo 2020. Il portafoglio dismesso comprende una selezione di prodotti farmaceutici da banco e soggetti a ricetta medica cTakeda schließt Verkauf von ausgewählten rezeptfreien und nicht zum Kerngeschäft gehörenden Aktiva an Hypera Pharma ab
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) („Takeda“) hat heute den Abschluss der zuvor angekündigten Veräußerung eines Portfolios ausgewählter Produkte in Lateinamerika an Hypera S.A. („Hypera Pharma“) mit einem Gesamtwert von 825 Millionen US-Dollar bekannt gegeben. Diese Veräußerungsvereinbarung wurde erstmals im März 2020 publik gemacht. Das veräußerte Portfolio umfasst bestimmte rezeptfreie und verschreibungspflichtige pharmazeutische Produkte,Takeda completa la venta de activos no esenciales y productos de venta libre seleccionados a Hypera Pharma
OSAKA, Japón--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) anunció hoy la finalización de la previamente anunciada venta de una cartera de productos seleccionados vendidos en Latinoamérica a Hypera S.A. (“Hypera Pharma”) por un valor total de 825 millones de dólares. Este acuerdo de venta se anunció por primera vez en marzo de 2020. La cartera objeto de la venta incluye productos farmacéuticos de venta libre y con receta seleccionados que se venden en BrTakeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products sold in Latin America to Hypera S.A. (“Hypera Pharma”) for a total value of $825 million USD. This divestment agreement was first announced in March 2020. The divested portfolio includes select over-the-counter and prescription pharmaceutical products sold in Brazil, Mexico, and other South American,
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hypera Pharma
Sign Up For FreeTo access detailed company insights
Founded in 2001, Hyper Pharma is a full service pharmaceutical company. Hyper Pharma is divided into three business segements, prescription products, consumer health, and generic and similar brand prescriptions. Hyper Pharma is headquartered out of Sao Paulo, Brazil.... Read More
